Stock Analysis on Net
Stock Analysis on Net

Allergan Inc. (NYSE:AGN.)

$22.49

This company has been moved to the archive! The financial data has not been updated since February 19, 2015.

Enterprise Value (EV)

Microsoft Excel

Paying user area

Try for free

Allergan Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Current Enterprise Value (EV)

Allergan Inc., current enterprise value calculation

Microsoft Excel
Current share price (P)
No. shares of common stock outstanding
US$ in thousands
Common equity (market value)1
Add: Preferred stock, $.01 par value; none issued (per books)
Add: Noncontrolling interest (per books)
Total equity
Add: Notes payable (per books)
Add: Convertible notes (per books)
Add: Long-term debt, excluding current maturities (per books)
Total equity and debt
Less: Cash and equivalents
Less: Short-term investments
Enterprise value (EV)

Based on: 10-K (reporting date: 2014-12-31).

1 Common equity (market value) = Share price × No. shares of common stock outstanding
= ×

Historical Enterprise Value (EV)

Allergan Inc., EV calculation

Microsoft Excel
Dec 31, 2014 Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Share price1, 2
No. shares of common stock outstanding1
US$ in thousands
Common equity (market value)3
Add: Preferred stock, $.01 par value; none issued (book value)
Add: Noncontrolling interest (book value)
Total equity
Add: Notes payable (book value)
Add: Convertible notes (book value)
Add: Long-term debt, excluding current maturities (book value)
Total equity and debt
Less: Cash and equivalents
Less: Short-term investments
Enterprise value (EV)

Based on: 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31).

1 Data adjusted for splits and stock dividends.

2 Closing price as at the filing date of Allergan Inc. Annual Report.

3 2014 Calculation
Common equity (market value) = Share price × No. shares of common stock outstanding
= ×

Common Equity (Market Value)
The common equity displayed a consistent upward trend over the five-year period. Starting at approximately 22.3 billion USD at the end of 2010, it increased steadily each year, reaching nearly 69.4 billion USD by the end of 2014. This significant increase indicates a substantial growth in shareholder value and market capitalization over the period.
Total Equity
Total equity values closely parallel the common equity figures, beginning at about 22.3 billion USD in 2010 and rising to approximately 69.4 billion USD by 2014. The parallel movement suggests minimal differences between common equity and total equity, with both showing strong, consistent growth throughout the period.
Total Equity and Debt
The combined total of equity and debt shows an increasing trend from roughly 24.5 billion USD in 2010 to about 71.6 billion USD in 2014. The growth rate is steady each year, suggesting that the company’s overall capital structure expanded significantly, with increases potentially in both equity and debt financing components.
Enterprise Value (EV)
Enterprise value also rose consistently from approximately 21.8 billion USD at the end of 2010 to nearly 66.6 billion USD in 2014. The increase in EV aligns with the upward trends seen in equity and total capitalization, reflecting an overall expansion in the company's market valuation including its debt and other financial obligations.